Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological MalignanciesXinping Cao, Mingfeng Zhao, Xin Jin et al.|Current Treatment Options in Oncology|2023Cited by 25
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantationWenyi Lu, Mingfeng Zhao, Meng Zhang et al.|Leukemia|2024Cited by 11
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Cancer Immunology Immunotherapy|2024Cited by 7
A CAR-T response prediction model for r/r B-NHL patients based on a T-cell subset nomogramXiaomei Zhang, Mingfeng Zhao, Rui Sun et al.|Research Square|2023Cited by 0
A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysisShujing Guo, Jile Liu, Bing Wang et al.|Frontiers in Oncology|2025Cited by 0